Safety Study of Pyridostigmine in Heart Failure (APP-HF)

This study is currently recruiting participants. (see Contacts and Locations)
Verified December 2013 by New York University School of Medicine
Sponsor:
Collaborators:
Nathan Kline Institute for Psychiatric Research
Oklahoma State University
Information provided by (Responsible Party):
Stuart Katz, New York University School of Medicine
ClinicalTrials.gov Identifier:
NCT01415921
First received: August 10, 2011
Last updated: December 10, 2013
Last verified: December 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: August 2014
  Estimated Primary Completion Date: July 2014 (Final data collection date for primary outcome measure)